Resverlogix Aktie - RVX

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

0,04

Gebot

0,035

Fragen

0,04

Volumen

0,00 Tagesbereich 0,00

0,035 52-Wochen-Bereich 0,095

Marktkapitalisierung

10,895M

Handelsende

0,04

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

43.373

Ausgegebene Aktien

272.371.000

Dividendenrendite

Kurs-Gewinn-Verhältnis

-0,65

Gewinn pro Aktie (EPS)

-0,06

Erlöse

57k

Nettogewinn

-16,74M

Sektor

Biological Pds,ex Diagnstics

Branche

Biological Pds,ex Diagnstics

Website

www.resverlogix.com

Hauptsitz

Calgary, Alberta, Can

Gegründet

Resverlogix Corp is listed in the Biological Pds,ex Diagnstics sector of the Toronto Börse with ticker RVX. The last closing price for Resverlogix was $0,04. Over the last year, Resverlogix shares have traded in a share price range of $ 0,035 to $ 0,095.

Resverlogix currently has 272.371.000 shares in issue. The market capitalisation of Resverlogix is $10,89 million. Resverlogix has a price to earnings ratio (PE ratio) of -0.65.

InvestmentPitch Media Video Discusses Resverlogix and its Focus on Apabetalone’s Future Development for the Prevention and Treatment of Post COVID-19 Conditions

VANCOUVER, British Columbia, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. (TSX:RVX) (OTCPink:RVXCF...

Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions

CALGARY, Alberta, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the “Company”...

Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease

CALGARY, Alberta, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today...

Resverlogix Announces Appointment of New Chief Scientific Officer

CALGARY, Alberta, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today...

Resverlogix Announces Voting Results from the 2022 Meeting of Shareholders

CALGARY, Alberta, June 21, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix”, or the "Corporation...

Resverlogix Announces New Research Findings Highlighting the Safety of BD2-selective BET Inhibitors

CALGARY, Alberta, June 08, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today...

Resverlogix Announces Type C Meeting with FDA for CORAL, a Phase 3 High-risk COVID-19 Outpatient Study

CALGARY, Alberta, May 09, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix", or "the Company...

Resverlogix Announces One-Year Extension of Debenture

CALGARY, Alberta, April 19, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the “Company”...

Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine

CALGARY, Alberta, March 17, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today...

Resverlogix Corp. to Webcast Live at VirtualInvestorConferences.com March 10th

CALGARY, Alberta, March 09, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX), a global...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0.04	0.045	0.035	123626	0.04007078	CS
4	-0.005	-11.1111111111	0.045	0.05	0.035	54021	0.04260909	CS
12	-0.01	-20	0.05	0.055	0.035	43373	0.04558926	CS
26	-0.02	-33.3333333333	0.06	0.065	0.035	51561	0.05266987	CS
52	-0.01	-20	0.05	0.095	0.035	59777	0.06168429	CS
156	-0.39	-90.6976744186	0.43	0.445	0.035	66065	0.12325099	CS
260	-0.85	-95.5056179775	0.89	1.52	0.035	62994	0.3679626	CS

RVX - Frequently Asked Questions (FAQ)

What is the current Resverlogix share price?

The current share price of Resverlogix is $ 0,04

How many Resverlogix shares are in issue?

Resverlogix has 272.371.000 shares in issue

What is the market cap of Resverlogix?

The market capitalisation of Resverlogix is CAD 10,89M

What is the 1 year trading range for Resverlogix share price?

Resverlogix has traded in the range of $ 0,035 to $ 0,095 during the past year

What is the PE ratio of Resverlogix?

The price to earnings ratio of Resverlogix is -0,65

What is the cash to sales ratio of Resverlogix?

The cash to sales ratio of Resverlogix is 200

What is the reporting currency for Resverlogix?

Resverlogix reports financial results in USD

What is the latest annual turnover for Resverlogix?

The latest annual turnover of Resverlogix is USD 57k

What is the latest annual profit for Resverlogix?

The latest annual profit of Resverlogix is USD -16,74M

What is the registered address of Resverlogix?

The registered address for Resverlogix is 4820 RICHARD ROAD S.W, SUITE 300, CALGARY, ALBERTA, T3E 6L1

What is the Resverlogix website address?

The website address for Resverlogix is www.resverlogix.com

Which industry sector does Resverlogix operate in?

Resverlogix operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
134AUPraise Inc	0,00 (0,00%)	0
1332Nissui Corporation	0,00 (0,00%)	0
132AIN Holdings Co Ltd	0,00 (0,00%)	0
131ACCN Group Corp	0,00 (0,00%)	0
130AVeritas In Silico Inc	0,00 (0,00%)	0
134AUPraise Inc	0,00 (0,00%)	0
1332Nissui Corporation	0,00 (0,00%)	0
132AIN Holdings Co Ltd	0,00 (0,00%)	0
131ACCN Group Corp	0,00 (0,00%)	0
130AVeritas In Silico Inc	0,00 (0,00%)	0
134AUPraise Inc	0,00 (0,00%)	0
1332Nissui Corporation	0,00 (0,00%)	0
132AIN Holdings Co Ltd	0,00 (0,00%)	0
131ACCN Group Corp	0,00 (0,00%)	0
130AVeritas In Silico Inc	0,00 (0,00%)	0

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Resverlogix Corp (RVX)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Resverlogix Corp

RVX Neueste Nachrichten

InvestmentPitch Media Video Discusses Resverlogix and its Focus on Apabetalone’s Future Development for the Prevention and Treatment of Post COVID-19 Conditions

Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions

Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease

Resverlogix Announces Appointment of New Chief Scientific Officer

Resverlogix Announces Voting Results from the 2022 Meeting of Shareholders

Resverlogix Announces New Research Findings Highlighting the Safety of BD2-selective BET Inhibitors

Resverlogix Announces Type C Meeting with FDA for CORAL, a Phase 3 High-risk COVID-19 Outpatient Study

Resverlogix Announces One-Year Extension of Debenture

Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine

Resverlogix Corp. to Webcast Live at VirtualInvestorConferences.com March 10th

RVX - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Resverlogix Corp (RVX) Börsenkurse

Resverlogix Corp (RVX)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Resverlogix Corp

RVX Neueste Nachrichten

InvestmentPitch Media Video Discusses Resverlogix and its Focus on Apabetalone’s Future Development for the Prevention and Treatment of Post COVID-19 Conditions

Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions

Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease

Resverlogix Announces Appointment of New Chief Scientific Officer

Resverlogix Announces Voting Results from the 2022 Meeting of Shareholders

Resverlogix Announces New Research Findings Highlighting the Safety of BD2-selective BET Inhibitors

Resverlogix Announces Type C Meeting with FDA for CORAL, a Phase 3 High-risk COVID-19 Outpatient Study

Resverlogix Announces One-Year Extension of Debenture

Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine

Resverlogix Corp. to Webcast Live at VirtualInvestorConferences.com March 10th

RVX - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen